The Sunshine Reporter

DelveInsight Business Research LLP

DelveInsight has launched a new report on “Parkinson’s Disease (PD) – Market Insights, Epidemiology, and Market Forecast-2030”.

DelveInsight’s “Parkinson’s Disease (PD) – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Parkinson’s Disease (PD), historical and forecasted epidemiology as well as the  Parkinson’s Disease (PD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Some of the key facts of the Report:

1. The total diagnosed prevalent population of Parkinson’s disease in the 7MM is expected to rise to 3,284,084 in 2030, during the study period [2017–2030]. Estimates show the highest diagnosed prevalent population of Parkinson’s disease is in the United States followed by Japan

Key benefits of the report:

1. Parkinson’s Disease (PD) market report covers a descriptive overview and comprehensive insight of the Parkinson’s Disease (PD) epidemiology and Parkinson’s Disease (PD) market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)

2. The Parkinson’s Disease (PD) market report provides insights on the current and emerging therapies.

3. Parkinson’s Disease (PD) market report provides a global historical and forecasted market covering drug outreach in 7MM.

4. The Parkinson’s Disease (PD) market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Parkinson’s Disease (PD) market.

Request for sample pages: https://www.delveinsight.com/sample-request/parkinsons-disease-market-size-analysis-treatment

Parkinson’s Disease (PD): Overview

Parkinson’s disease is a progressive disorder that is caused by degeneration of nerve cells in the part of the brain called the substantia nigra, which controls movement. Most people with Parkinson’s start to develop symptoms when they’re over 50, although around one in 20 people with the condition first experience symptoms when they’re under 40.

The key players involved in the Parkinson’s Disease (PD) market:

1. Neurocrine Biosciences/Voyager Therapeutics

2. Kyowa Kirin

3. Neurocrine Biosciences

4. Pharma Two B Ltd

5. Luye Pharma

6. AbbVie

7. Sunovion Pharma

The launch of the emerging therapies is expected to significantly impact the Parkinson’s Disease (PD) treatment scenario in the upcoming years:-

Drug covered

1. VY-AADC

2. Istradefylline

3. Opicapone

4. P2B001

5. LY03003

6. ABBV-951

7. APL-130277

Request a free sample report @https://www.delveinsight.com/sample-request/parkinsons-disease-market-size-analysis-treatment

Table of Contents

1. Report Introduction

2. Executive Summary

3. SWOT analysis

4. Parkinson’s Disease (PD) Patient Share (%) Overview at a Glance

5. Parkinson’s Disease (PD) Market Overview at a Glance

6. Parkinson’s Disease (PD) Disease Background and Overview

7. Parkinson’s Disease (PD) Epidemiology and Patient Population

8. Country-Specific Patient Population of Parkinson’s Disease (PD)

9. Parkinson’s Disease (PD) Current Treatment and Medical Practices

10. Unmet Needs

11. Parkinson’s Disease (PD) Emerging Therapies

12. Parkinson’s Disease (PD) Market Outlook

13. Country-Wise Parkinson’s Disease (PD) Market Analysis (2017–2030)

14. Market Access and Reimbursement of Therapies

15. Market drivers

16. Market barriers

17. Appendix

18. Parkinson’s Disease (PD) Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

Related Reports:

Parkinson’s Disease- Pipeline Insights, 2021

“Parkinson’s Disease Pipeline Insight, 2021” report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Parkinson’s Disease market. A detailed picture of the Parkinson’s Disease pipeline landscape is provided, which includes the disease overview and Parkinson’s Disease treatment guidelines.

Parkinson’s Disease -Epidemiology Forecast to 2030

DelveInsight’s ‘Parkinson’s Disease – Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Parkinson’s Disease epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/